Lily Kim is Associate Director of Platform Development at the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she focuses on technology translation and commercialization strategy. Her technical expertise in microfluidics and lab-on-a-chip systems. Lily has a Ph.D. in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology and an S.B. in electrical engineering from MIT. During her graduate studies she was awarded a Hertz Foundation fellowship and developed microfluidic devices for investigating embryonic stem cell biology. Her interests include the commercialization of microfluidic and biomedical technology, technology strategy, and the process of technology evolution.
(The opinions shared here are my own and do not necessarily reflect the views held by the Wyss Institute.)